Clinical Trials Browser

Phase 4 × Cardiotoxicity × Breast × Clear all

NCT04928261 2026-01-22

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Phase 4 Active not recruiting

Breast Neoplasms, Cardiotoxicity

NCT02696707 2025-12-18

OTT 15-05

Phase 4 Completed

200 enrolled 8 charts

Breast Neoplasms, Cardiotoxicity

NCT07254221 2025-12-10

ROSUBREAST

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT04434404 2020-06-16

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Phase 4 Completed

Breast Neoplasms, Cardiotoxicity